![PCE artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts124/v4/94/32/1a/94321aaa-4adf-3df2-4810-f996719b6b1e/mza_11695467358112480520.jpg/100x100bb.jpg)
EUAs and Vaccines
PCE
English - April 30, 2021 21:39 - 21 minutes - 19.6 MB - ★★★★ - 6 ratingsCourses Education Science Life Sciences app education np education podcasts for credit app medicine pa education np medicine pa medicine ce podcasts app podcasts cme podcasts Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
In the global effort to address the COVID-19 pandemic, healthcare practitioners need to stay up to date as the Emergency Use Authorization (EUAs) for treatments and vaccines change rapidly. This 6-part podcast series opens with a discussion of how EUAs work and how they are different from full approval. In the subsequent episodes, experts explain the latest evidence-based information on inpatient and outpatient antiviral treatments, the most recent information on available vaccines, and how the emerging SARS-CoV-2 variants impact our COVID-19 toolbox.This episode provides an overview of the rapid development of vaccines currently under Emergency Use Authorization (EUA) for the prevention of SARS-CoV-2 in the United States. An expert describes the mechanisms of action for the mRNA and viral vector vaccines, as well as efficacy, side effects, and post-vaccine safety assessment. The conversation concludes with a review of what is needed to achieve herd immunity, and guidance for people who are fully vaccinated. Claim your credit at pce.is/COV19.